Cargando…
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606812/ https://www.ncbi.nlm.nih.gov/pubmed/19092168 http://dx.doi.org/10.2337/dc08-9026 |
_version_ | 1782162987290722304 |
---|---|
author | Skyler, Jay S. Bergenstal, Richard Bonow, Robert O. Buse, John Deedwania, Prakash Gale, Edwin A.M. Howard, Barbara V. Kirkman, M. Sue Kosiborod, Mikhail Reaven, Peter Sherwin, Robert S. |
author_facet | Skyler, Jay S. Bergenstal, Richard Bonow, Robert O. Buse, John Deedwania, Prakash Gale, Edwin A.M. Howard, Barbara V. Kirkman, M. Sue Kosiborod, Mikhail Reaven, Peter Sherwin, Robert S. |
author_sort | Skyler, Jay S. |
collection | PubMed |
description | |
format | Text |
id | pubmed-2606812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-26068122010-01-01 Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association Skyler, Jay S. Bergenstal, Richard Bonow, Robert O. Buse, John Deedwania, Prakash Gale, Edwin A.M. Howard, Barbara V. Kirkman, M. Sue Kosiborod, Mikhail Reaven, Peter Sherwin, Robert S. Diabetes Care Reviews/Commentaries/ADA Statements American Diabetes Association 2009-01 /pmc/articles/PMC2606812/ /pubmed/19092168 http://dx.doi.org/10.2337/dc08-9026 Text en Copyright © 2009, American Diabetes Association https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Reviews/Commentaries/ADA Statements Skyler, Jay S. Bergenstal, Richard Bonow, Robert O. Buse, John Deedwania, Prakash Gale, Edwin A.M. Howard, Barbara V. Kirkman, M. Sue Kosiborod, Mikhail Reaven, Peter Sherwin, Robert S. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association |
title | Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
|
title_full | Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
|
title_fullStr | Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
|
title_full_unstemmed | Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
|
title_short | Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
|
title_sort | intensive glycemic control and the prevention of cardiovascular events: implications of the accord, advance, and va diabetes trials: a position statement of the american diabetes association and a scientific statement of the american college of cardiology foundation and the american heart association |
topic | Reviews/Commentaries/ADA Statements |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606812/ https://www.ncbi.nlm.nih.gov/pubmed/19092168 http://dx.doi.org/10.2337/dc08-9026 |
work_keys_str_mv | AT skylerjays intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio AT bergenstalrichard intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio AT bonowroberto intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio AT busejohn intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio AT deedwaniaprakash intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio AT galeedwinam intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio AT howardbarbarav intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio AT kirkmanmsue intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio AT kosiborodmikhail intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio AT reavenpeter intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio AT sherwinroberts intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio |